Savient Pharma (SVNT) Shares Nosedive as Co. Served with Credit Derivative Action
Tweet Send to a FriendGet Alerts SVNT Hot Sheet
Up)
Trade SVNT Now!
Shares of Savient Pharma (Nasdaq: SVNT) are plunging midday Tuesday following an 8-K filing which disclosed the company was served with a creditor derivative action. The complaint was filed by Tang Capital.
The stock is now down a whopping 28 percent to around $1.71.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock is now down a whopping 28 percent to around $1.71.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Canadian Solar (CSIQ) Continues Higher Following Arbitration Win Over LDK (LDK)
- Pandora (P) Gets Even More Social with New Facebook (FB) Timeline App
- Domino's Pizza (DPZ) Added to S&P MidCap 400, Cynosure (CYNO) to S&P SmallCap 600
Create E-mail Alert Related Categories
Corporate News, Momentum MoversRelated Entities
Tang Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
